Home/Filings/4/0000950170-25-027101
4//SEC Filing

Ryan Jason 4

Accession 0000950170-25-027101

CIK 0001850906other

Filed

Feb 24, 7:00 PM ET

Accepted

Feb 25, 8:08 PM ET

Size

12.6 KB

Accession

0000950170-25-027101

Insider Transaction Report

Form 4
Period: 2025-02-21
Ryan Jason
Director
Transactions
  • Disposition to Issuer

    Stock Option (Right to Buy)

    2025-02-211,3330 total
    Exercise: $672.90Exp: 2031-05-05Common Stock (1,333 underlying)
  • Disposition to Issuer

    Stock Option (Right to Buy)

    2025-02-211,5410 total
    Exercise: $85.80Exp: 2032-05-26Common Stock (1,541 underlying)
  • Disposition to Issuer

    Stock Option (Right to Buy)

    2025-02-21$8.84/sh2,466$21,7990 total
    Exercise: $11.16Exp: 2034-05-29Common Stock (2,466 underlying)
  • Disposition to Issuer

    Stock Option (Right to Buy)

    2025-02-212,4660 total
    Exercise: $31.80Exp: 2033-05-25Common Stock (2,466 underlying)
Footnotes (2)
  • [F1]Pursuant to the Agreement and Plan of Merger, dated as of December 22, 2024 (the "Merger Agreement"), by and among the Issuer, Singular Genomics Parent, LLC, a Delaware limited liability company, and Saturn Merger Sub, Inc., a Delaware corporation, and after giving effect to the acceleration treatment set forth in footnote (2), each vested stock option was cancelled and automatically converted into the right to receive an amount in cash determined by multiplying (x) the excess, if any, of the amount of $20.00 per share over the applicable exercise price of such option by (y) the number of vested shares subject to such option (the "Option Payment"), less all applicable deductions and withholdings; provided, however, that the Option Payment for each option with an exercise price equal to or greater than $20.00 was $0 and such option was cancelled for no consideration.
  • [F2]As of the effective time of the merger contemplated within the Merger Agreement, each outstanding option, to the extent unvested, was accelerated and became fully vested and exercisable.

Documents

1 file

Issuer

Singular Genomics Systems, Inc.

CIK 0001850906

Entity typeother

Related Parties

1
  • filerCIK 0001585017

Filing Metadata

Form type
4
Filed
Feb 24, 7:00 PM ET
Accepted
Feb 25, 8:08 PM ET
Size
12.6 KB